Approval · Notice of Compliance 15441 · 2014
INLYTA: Notice of Compliance 15441
Issued March 24, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15441
- Date
- March 24, 2014
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths - 3.0 mg and 7.0 mg
- Therapeutic class
- Kinase inhibitor, anti-tumour agent